Capvizr
THE DEAL, AT A GLANCE

Mandrake Bio

From the announcement
01What it doesAccelerating Agriculture And Genetic Medicine Mandrake Bio’s technology is designed to reduce the time required to develop improved crop varieties through precision gene…From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
02Who is involvedBacked by Activate, Antler, as the company looks, Spectrum ImpactFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
03What happenedMandrake Bio raised $1.1M Pre-Seed, announced 2026-07-16From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
04Why it mattersMandrake Bio's $1.1M Pre-Seed positions the company as a small early-stage capital allocation within an active Healthcare & Life Sciences funding market, with the round…From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Mandrake Bio · Financing Record

Explore source-linked visual explanations for Mandrake Bio. Unsupported claims are withheld while source review continues.

Record 8310 · Recorded date: 2026-07-16

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime